Akt phosphorylation in lymphocytes provides an index of in vitro insulin-like growth factor I sensitivity associated with growth hormone-induced growth

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 4, 2008, Pages 1458-1463

  Lotton, Chantal ^a,b   Rodrigue, Danielle ^a   Elie, Caroline ^c   Rothenbühler, Anya ^a   Lahlou, Najiba ^a   Le Stunff, Catherine ^b   Bougnè, Pierre ^a,b  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b INSERM   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; PROTEIN KINASE B; SOMATOMEDIN C;

ARTICLE; CHILD GROWTH; CLINICAL ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GROWTH RATE; HORMONAL THERAPY; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; OSTEOBLAST; PHARMACOGENETICS; PRIORITY JOURNAL; SHORT STATURE; SIGNAL TRANSDUCTION; SMALL FOR DATE INFANT;

EID: 42049095702     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2575     Document Type: Article

References (32)

1. Vance ML, Mauras N 1999 Growth hormone therapy in adults and children. N Engl J Med 341:1206-1216
2. Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P 2004 A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 36:720-724
3. Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K 1996 Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age. J Clin Endocrinol Metab 81:3902-3908
4. Kamp GA, Zwinderman AH, Van Doorn J, Hackeng W, Frolich M, Schonau E, Wit JM 2002 Biochemical markers of growth hormone (GH) sensitivity in children with idiopathic short stature: individual capacity of IGF-I generation after high-dose GH treatment determines the growth response to GH. Clin Endocrinol (Oxf) 57:315-325
5. Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ, Crowe BJ, Ross JL, Cassorla FG, Blum WF, Cutler Jr GB, Baron J 2004 Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 89:3140-3148
6. Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG 2007 Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. J Clin Endocrinol Metab 92:2480-2486
7. Frank GR, Cheung PT, Horn JA, Alfaro MP, Smith EP, Chernausek SD 1996 Predicting the growth response to growth hormone in patients with intrauterine growth retardation. Clin Endocrinol (Oxf) 44:679-685
8. Daughaday W 1988 Endocrinology-the way we were: a personal history of somatomedin. Anal Chem 40:586
9. Clemens TL, Chernausek SD 2004 Genetic strategies for elucidating insulin-like growth factor action in bone. Growth Horm IGF Res 14:195-199
10. Denley A, Cosgrove LJ, Booker GW, Wallace JC, Forbes BE 2005 Molecular interactions of the IGF system. Cytokine Growth Factor Rev 16:421-439
11. Roberts CJ 2003 Insulin-like growth factor signaling. In: Henry HL, Norman AW, eds. Encyclopedia of hormones. Boston, MA: Academic Press; 354-359
12. Roberts CJ 2004 The role of insulin-like growth factor system in pre- and post-natal growth, development, and tumorigenesis. In: Houston MS, Holly JMP, Feldman EL, eds. IGF, nutrition, and health. Totowa, NJ: Humana Press; 121-132
13. Entingh-Pearsall A, Kahn CR 2004 Differential roles of the insulin and insulin-like growth factor-I (IGF-I) receptors in response to insulin and IGF-I. J Biol Chem 279:38016-38024
14. Duan C 2002 Specifying the cellular responses to IGF signals: roles of IGF-binding proteins. J Endocrinol 175:41-54
15. LeRoith D, Werner H, Beitner-Johnson D, Roberts Jr CT 1995 Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163
16. Moxham CP, Duronio V, Jacobs S 1989 Insulin-like growth factor I receptor β-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers. J Biol Chem 264:13238-13244
17. Li G, Barrett EJ, Wang H, Chai W, Liu Z 2005 Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells. Endocrinology 146:4690-4696
18. Slaaby R, Schaffer L, Lautrup-Larsen I, Andersen AS, Shaw AC, Mathiasen IS, Brandt J 2006 Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-I affinity irrespective of the IR splice variant. J Biol Chem 281:25869-25874
19. Denley A, Carroll JM, Brierley GV, Cosgrove L, Wallace J, Forbes B, Roberts Jr CT 2007 Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors. Mol Cell Biol 27:3569-3577
20. Johnston AM, Pirola L, Van Obberghen E 2003 Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling. FEBS Lett 546:32-36
21. White MF 2002 IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 283:E413-E422
22. Fruman DA, Meyers RE, Cantley LC 1998 Phosphoinositide kinases. Annu Rev Biochem 67:481-507
23. Vanhaesebroeck B, Alessi DR 2000 The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346(Pt 3):561-576
24. Okkenhaug K, Vanhaesebroeck B 2003 PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol 3:317-330
25. Stentz FB, Kitabchi AE 2003 Activated T lymphocytes in Type 2 diabetes: implications from in vitro studies. Curr Drug Targets 4:493-503
26. Stentz FB, Kitabchi AE 2004 Transcriptome and proteome expression in activated human CD4 and CD8 T-lymphocytes. Biochem Biophys Res Commun 324:692-696
27. Kane LP, Weiss A 2003 The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunol Rev 192:7-20
28. 1997 World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 227:925-926
29. R Development Core Team 2006 R: a language and environment to statistical computing. Vienna: R Foundation for Statistical Computing
30. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, Kiess W, Klammt J, Kratzsch J, Osgood D, Pfaffle R, Raile K, Seidel B, Smith RJ, Chernausek SD 2003 IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 349:2211-2222
31. Ranke MB 2005 Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance. Trends Endocrinol Metab 16:190-197
32. Goring HH, Curran JE, Johnson MP, Dyer TD, Charlesworth J, Cole SA, Jowett JB, Abraham LJ, Rainwater DL, Comuzzie AG, Mahaney MC, Almasy L, Maccluer JW, Kissebah AH, Collier GR, Moses EK, Blangero J 2007 Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes. Nat Genet 39:1208-1216